Clinical Trials Logo

Colon Cancer clinical trials

View clinical trials related to Colon Cancer.

Filter by:

NCT ID: NCT04762914 Completed - Colon Cancer Clinical Trials

Observing the Perioperative Effects of Prehabilitation in Colorectal Cancer Patients

Start date: September 1, 2018
Phase:
Study type: Observational

Quality Improvement Project to evaluate how prehabilitation can be incorporated into our colorectal cancer pathway and assess its clinical benefits.

NCT ID: NCT04732442 Completed - Colon Cancer Clinical Trials

Changes in Inflammatory Response After Immunonutrition Compared to Standard Nutrition in Colorectal Cancer Tissue

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

It is Randomized Controlled Trial, in which investigators will estimate the impact of the use of immunonutrition support compared to standard nutritional support in the preoperative period in patients with colorectal cancer.

NCT ID: NCT04729738 Completed - Sarcopenia Clinical Trials

The Patient in Laparoscopic Colon Surgery:Impact of Comorbidities,Frailty,Malnutrition and Sarcopenia on Short-term Mortality

Start date: June 1, 2012
Phase:
Study type: Observational

There are many factors involved in outlining the patient's profile and in defining which factors can be configured as risks related to the surgical act; for the modern surgeon it is no longer possible to identify the patient at risk of complications based on the mere age or some comorbidities historically considered more influential on the surgical outcome, but each patient must be evaluated in its entirety including age, fragility, comorbidity, state nutritional and sarcopenia and, if necessary, implementing preoperative therapeutic strategies aimed at minimizing the impact of some of these factors on the outcome of surgery. Our study aimed at creating, if possible, an "identikit" of the patient who is more likely to have serious postoperative complications; in order to improve the therapeutic decision and the approach to patients with severe surgical risk since choosing the right treatment for the right patient is essential to obtain a good result.

NCT ID: NCT04630327 Completed - Breast Cancer Clinical Trials

Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory

Start date: January 13, 2020
Phase:
Study type: Observational

Depression and anxiety in female patients with cancer are serious comorbidities that affect the quality of life for patients and their survival rates as they have poorer health outcomes. This validation study is a part of the study on the prevalence of depression and anxiety among breast cancer patients. This study aims to investigate the validity of the Kazakh and Russian versions of the Beck Depression Inventory (BDI-II) and Beck Anxiety Inventory (BAI) among female cancer patients in Almaty, Kazakhstan.

NCT ID: NCT04548531 Completed - Colon Cancer Clinical Trials

Engaging Patients in Colon Cancer Screening Decisions During COVID-19

Start date: September 10, 2020
Phase: N/A
Study type: Interventional

The goal of the study is to examine whether a shared decision making intervention improves decision making about colon cancer screening for patients who had their colonoscopy delayed or postponed due to the COVID pandemic. Eligible patients (n=800) will be randomly assigned to either the intervention or control arm. A subset will be surveyed about 6-8 weeks post intervention to measure shared decision making, their intention to follow through with screening, and their decisional conflict. Study staff will conduct medical chart review to track receipt of colon cancer screening within 6 months. The statistician will test whether patients in the intervention arm report more shared decision making, less decisional conflict, higher intention to follow through on screening and have higher screening rates compared to those in the control arm.

NCT ID: NCT04540081 Completed - Obesity Clinical Trials

Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer

CLOVER
Start date: October 5, 2020
Phase: N/A
Study type: Interventional

The purpose of CLOVER is to utilize Epic Healthy Planet to increase adherence to United States Preventive Services Task Force (USPSTF) and Centers for Disease Control and Prevention (CDC) recommendations in adults age 50 and older.

NCT ID: NCT04538404 Completed - Surgery Clinical Trials

Mortality Score in Elderly Patients With Colon Cancer

MECC
Start date: January 1, 2011
Phase:
Study type: Observational

CR-POSSUM is one of the most used surgical scores to predict mortality after colorectal surgery. Its main drawback is the requirement of intraoperative variables, whose collection is time-consuming and prevents from obtaining a purely preoperative risk assessment. The primary aim of the study is to develop a new surgical score using preoperative parameters to predict 30-day mortality after colon cancer surgery in the elderly population. The secondary objective is to analyze its efficacy compared to CR-POSSUM.

NCT ID: NCT04532515 Completed - Colon Cancer Clinical Trials

Seal-G / Seal-G MIST Study

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

A prospective, multi-center, open label, study to evaluate safety and performance of Seal-G and Seal-G MIST in reinforcing colonic anastomosis, in subjects undergoing Colon Resection surgery

NCT ID: NCT04517708 Completed - Gastric Cancer Clinical Trials

Effectiveness of Nutritional Interventions for Cancer Patients Undergoing Chemotherapy

Start date: January 15, 2016
Phase: N/A
Study type: Interventional

This study aims to estimate the effects of nutritional interventions on the improvement of nutritional status and quality of life (QoL) among gastrointestinal patients in Vietnam

NCT ID: NCT04497935 Completed - Colon Cancer Clinical Trials

Comparison of Two Preparations for the Study of the Colon Through Colonoscopy

Start date: January 1, 2019
Phase:
Study type: Observational

Compare the quality of bowel preparation between two groups of patients, who will undergo two different preparations: 1. Moviprep + diet; 2. Plenvu + diet